Cleveland HeartLab Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Cleveland HeartLab Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011437
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cleveland HeartLab Inc (Cleveland HeartLab) is a clinical laboratory that provides cardiovascular testing services. The company offers services such as cardiovascular risk assessment, novel diagnostic tests, inflammatory and other advanced biomarker testing, management and prevention of heart disease, cardiovascular treatment and intellectual property portfolio services. Its testing services comprise inflammation testing, fatty acids, harmone, genetics, hypertention and heart failure, thyroid function, anemia, routein panels, standard laboratory test, advanced lipid testing and other CV and metabolic testing services. Cleveland HeartLab offers testing services in the areas of advanced cholesterol assessment profile, alanine, amino transferase, albumin, aldolase, aldosterone, DHEA, cancer, cholesterol, oral glucose tolerance, blood, and other tests. The company partners with academic and medical institutions. Cleveland HeartLab is headquartered in Cleveland, Ohio, the US.

Cleveland HeartLab Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cleveland HeartLab Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cleveland HeartLab Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cleveland HeartLab Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cleveland HeartLab Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Cleveland HeartLab Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cleveland HeartLab Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Cleveland HeartLab Acquires Mirisk Cardiovascular Disease Risk Assessment Tool from Stanford University School of Medicine 10
Venture Financing 11
Cleveland HeartLab Raises USD3 Million in Venture Financing 11
Cleveland HeartLab Raises US$14.7 Million In Venture Financing 12
Cleveland HeartLab Secures US$18.4 Million In Series B Financing 13
Partnerships 14
Cleveland Clinic Enters into Agreement with Procter & Gamble and Cleveland HeartLab 14
Acquisition 15
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 15
Cleveland HeartLab Inc – Key Competitors 17
Cleveland HeartLab Inc – Key Employees 18
Cleveland HeartLab Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
02/16/2016: Cleveland HeartLab Launches Only Clinical Test for Measuring TMAO, an Important Measure of Gut Dysfunction that is Associated with Cardiovascular Disease Risk 20
Other Significant Developments 21
Mar 17, 2016: Cleveland HeartLab Partners with SK Telecom to Provide Valuable Cardiovascular Testing in China 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Cleveland HeartLab Inc, Medical Equipment, Key Facts 2
Cleveland HeartLab Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Cleveland HeartLab Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cleveland HeartLab Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cleveland HeartLab Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cleveland HeartLab Inc, Deals By Market, 2011 to YTD 2017 8
Cleveland HeartLab Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cleveland HeartLab Acquires Mirisk Cardiovascular Disease Risk Assessment Tool from Stanford University School of Medicine 10
Cleveland HeartLab Raises USD3 Million in Venture Financing 11
Cleveland HeartLab Raises US$14.7 Million In Venture Financing 12
Cleveland HeartLab Secures US$18.4 Million In Series B Financing 13
Cleveland Clinic Enters into Agreement with Procter & Gamble and Cleveland HeartLab 14
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 15
Cleveland HeartLab Inc, Key Competitors 17
Cleveland HeartLab Inc, Key Employees 18

★海外企業調査レポート[Cleveland HeartLab Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Data Respons ASA (DAT):企業の財務・戦略的SWOT分析
    Summary Data Respons ASA (Data Respons) is an information technology company that offers software products and embedded solutions. The company's products include storage and memory, handheld tablets, embedded boards, panel PCs and displays, systems and platforms, and industrial communication product …
  • Northwest Territories Power Corp:企業の戦略的SWOT分析
    Northwest Territories Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • MAN SE:企業の戦略・SWOT・財務分析
    MAN SE - Strategy, SWOT and Corporate Finance Report Summary MAN SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Silverleaf Resorts, Inc.:企業の戦略・SWOT・財務情報
    Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Shiseido Company, Limited:戦略・SWOT・企業財務分析
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Valeant Canada LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical products manufacturing company. The company offers products such as aczone, airomir, aldara, benzaclin topical gel, benzamycin, biacna topical gel, C.E.S. tablets, carbolith, ca …
  • MinebeaMitsumi Inc:戦略・SWOT・企業財務分析
    MinebeaMitsumi Inc - Strategy, SWOT and Corporate Finance Report Summary MinebeaMitsumi Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • US Physical Therapy Inc (USPH):企業の財務・戦略的SWOT分析
    US Physical Therapy Inc (USPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Zion Oil & Gas Inc (ZN):企業の財務・戦略的SWOT分析
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • China Datang Corp:電力:M&Aディール及び事業提携情報
    Summary China Datang Corp (CDT) is engaged in development, investment, construction, operation and management of power generation assets. The company provides electric power equipment, environment protection device, memory card and card reader; religion crafts, meter for electricity, safety products …
  • Berg LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Roka Bioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary Roka Bioscience Inc (Roka) is a manufacturer and distributor of molecular assays and instruments for food safety industry. The company offers products such as Atlas- automated molecular pathogen detection system, the listeria LSP detection assay, listeria monocytogenes Lmg2 detection assay, …
  • Talanx AG:企業の戦略・SWOT・財務情報
    Talanx AG - Strategy, SWOT and Corporate Finance Report Summary Talanx AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Berg LLC:医療機器:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • Bullfrog Power Inc.-エネルギー分野:企業M&A・提携分析
    Summary Bullfrog Power Inc. (Bullfrog Power) is a provider of green energy. The company offers renewable energy solutions that help businesses and houses in reducing their environmental impact. Bullfrog's product portfolio includes green electricity, green fuel and green natural gas. The company, th …
  • Altius Minerals Corp:企業の戦略・SWOT・財務情報
    Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report Summary Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SynDevRx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SynDevRx Inc (SDX) is a drug development company that develops treatments for cancer and metabolic dysfunction. The company offers lead compound SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active novel small molecule fumagillol derivative in vivo. Its servic …
  • Chubb European Group SE:企業の戦略的SWOT分析
    Chubb European Group SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆